Alternatives to Strattera (Atomoxetine) If You Can't Fill Your Prescription

Atomoxetine (formerly sold as brand-name Strattera) is the most well-studied non-stimulant medication for ADHD and has been in use since 2002. But if you're running into consistent difficulty filling your prescription — or if your doctor is considering your options — it helps to understand what alternatives exist, how they compare, and what to discuss at your next appointment.

Important: Never stop atomoxetine abruptly without consulting your prescriber. While atomoxetine doesn't cause withdrawal the way some medications do, your ADHD symptoms can return quickly. Work with your doctor on any transition plan.

Non-Stimulant Alternatives in the Same Drug Class

1. Qelbree (Viloxazine ER)

Qelbree (viloxazine extended-release) is the closest non-stimulant alternative to atomoxetine. Like atomoxetine, it is a selective norepinephrine reuptake inhibitor (sNRI), meaning it works through the same basic mechanism — increasing norepinephrine levels in the brain's prefrontal cortex. It was FDA-approved in 2021 for ADHD in patients ages 6 and older.

Key differences: Qelbree is taken once daily and the capsule can be opened and sprinkled on food — a potential advantage for patients who struggle to swallow pills. Some data suggest it may show effects within 2–4 weeks, compared to 4–8 weeks for atomoxetine. The main downsides: no generic is available yet (making it significantly more expensive), and it shares atomoxetine's black-box warning for suicidal ideation in children and adolescents.

2. Intuniv (Guanfacine ER)

Intuniv is the extended-release form of guanfacine, an alpha-2 adrenergic agonist. It works differently from atomoxetine — instead of blocking norepinephrine reuptake, it directly stimulates alpha-2 receptors in the prefrontal cortex to reduce ADHD symptoms. It is FDA-approved for ADHD in children and adolescents ages 6–17.

Generic guanfacine ER is widely available and typically less expensive than atomoxetine. Common side effects include drowsiness, low blood pressure, and dizziness. Unlike atomoxetine, guanfacine should not be stopped abruptly — it requires gradual tapering. It is not FDA-approved for adults, though some providers prescribe it off-label.

3. Kapvay (Clonidine ER)

Kapvay is the extended-release form of clonidine, another alpha-2 adrenergic agonist. Like Intuniv, it is FDA-approved for ADHD in children ages 6–17 and can be used as monotherapy or alongside stimulants. Clonidine tends to be more sedating than guanfacine, which can be a disadvantage during the day but a benefit for children with ADHD-related sleep difficulties.

Generic clonidine ER is available and typically the least expensive non-stimulant option. Like guanfacine, it requires gradual dose reduction to discontinue due to blood pressure effects.

Off-Label Non-Stimulant Alternatives

4. Wellbutrin (Bupropion)

Bupropion (Wellbutrin) is an antidepressant used off-label for ADHD — particularly in adults with comorbid depression. As a norepinephrine-dopamine reuptake inhibitor (NDRI), it affects both norepinephrine and dopamine pathways. It is not FDA-approved for ADHD, but clinical evidence supports its use, especially when depression and ADHD overlap. Generic bupropion is widely available and often affordable.

Stimulant Alternatives: First-Line Options for Many Patients

If you have been on atomoxetine because of concerns about controlled substances, but those concerns have changed — or if stimulants are clinically appropriate — they are actually considered first-line therapy for ADHD. Stimulants like methylphenidate (Ritalin, Concerta) and amphetamine-based medications (Adderall, Vyvanse) have larger effect sizes than non-stimulants in clinical studies and typically work within hours rather than weeks.

However, stimulants are Schedule II controlled substances, require a new prescription each month (no refills), and may not be appropriate for patients with certain cardiac conditions, a history of psychosis, or active substance use disorders. Discuss this candidly with your prescriber.

How to Compare Atomoxetine Alternatives: A Quick Reference

Here is a summary of how key alternatives compare to atomoxetine:

Qelbree: Same mechanism, faster onset (2–4 weeks), once-daily, no generic yet, approved ages 6+

Intuniv (guanfacine ER): Different mechanism, less sedating than clonidine, generic available, approved ages 6–17

Kapvay (clonidine ER): Most sedating non-stimulant, helpful for sleep issues, generic available, approved ages 6–17

Wellbutrin (bupropion): Off-label, useful for adults with depression+ADHD, generic widely available

Stimulants (Adderall, Vyvanse, Ritalin): First-line, largest effect sizes, immediate onset, controlled substance (Schedule II)

What to Tell Your Doctor

Before switching medications, make sure you've exhausted options for finding atomoxetine — it may be available at a different pharmacy. Read our guide on how to find atomoxetine in stock near you before assuming a switch is necessary.

If you do need to switch, be clear with your prescriber about: your ADHD symptom profile (primarily inattentive vs. hyperactive-impulsive), any comorbidities (anxiety, depression, substance use history), your age (some alternatives are not FDA-approved for adults), and your preferences about controlled substances.

The Bottom Line

Atomoxetine isn't the only non-stimulant option, and switching medications is sometimes the right call. But before you do, it's worth confirming the medication truly isn't available near you. Use medfinder to check pharmacies in your area, then have an informed conversation with your doctor about alternatives if needed.